The U.S. International Trade Commission today announced it will investigate certain sleep apnea devices made by Fisher & Paykel Healthcare following a complaint by ResMed that imported products violated its patents.
ResMed filed the complaint in August, according to the U.S. ITC, alleging “violations of section 337 of the Tariff Act of 1930” through the importation of sleep-disordered breathing masks and components by Fisher & Paykel which infringed on ResMed patents.
The allegations include both products from New Zealand-based Fisher & Paykel and 2 of its U.S. units in California.
